Taro Announces Approvals of ANDAs for Betamethasone Dipropionate Ointment (Augmented) and Ciprofloxacin Tablets
October 13, 2004 07:00 ET
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., Oct. 13, 2004 (PRIMEZONE) -- Taro Pharmaceutical Industries Ltd. ("Taro") (Nasdaq:TARO) reported today that Taro Pharmaceuticals U.S.A., Inc. ("Taro USA"), its U.S. affiliate, has...
Taro Receives FDA Approval For Loratadine Syrup, 5 mg / 5 ml ANDA
August 20, 2004 15:49 ET
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., Aug. 20, 2004 (PRIMEZONE) -- Taro Pharmaceutical Industries Ltd. (Nasdaq:TARO) ("Taro") reported today that it has received approval from the U.S. Food and Drug Administration...
Taro Receives Final Approval For Fluconazole Tablets ANDA
July 29, 2004 14:07 ET
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., July 29, 2004 (PRIMEZONE) -- Taro Pharmaceutical Industries Ltd. (Nasdaq:TARO) reported today that its U.S. affiliate has received final approval from the U.S. Food and Drug...
Taro to Report 2nd Quarter 2004 Results and Conduct Conference Call On July 29, 2004
July 27, 2004 20:03 ET
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., July 27, 2004 (PRIMEZONE) -- Taro Pharmaceutical Industries Ltd. (Nasdaq:TARO) intends to report financial results for the second quarter of 2004 prior to the Nasdaq market opening...
Taro Receives FDA Approval For Ammonium Lactate Lotion, 12% ANDA
June 01, 2004 09:39 ET
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., June 1, 2004 (PRIMEZONE) -- Taro Pharmaceutical Industries Ltd. (Nasdaq:TARO) reported today that its U.S. affiliate has received approval from the U.S. Food and Drug Administration...
Taro to Report 4th Quarter and Full Year 2003 Results and Conduct Conference Call on February 17, 2004
February 13, 2004 10:13 ET
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., Feb. 13, 2004 (PRIMEZONE) -- Taro Pharmaceutical Industries Ltd. (Nasdaq:TARO) intends to report financial results for the fourth quarter and full year 2003 prior to the Nasdaq...
Taro Expands U.S. Distribution Capacity with Purchase of New Jersey Facility
January 08, 2004 07:00 ET
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., Jan. 8, 2004 (PRIMEZONE) -- Taro Pharmaceutical Industries Ltd. (Nasdaq:TARO) today announced that its U.S. affiliate has expanded its distribution capacity with the purchase of a...
Taro Completes $50 Million Non-Convertible Debt Offering
December 01, 2003 07:00 ET
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., Dec. 01, 2003 (PRIMEZONE) -- Taro Pharmaceutical Industries Ltd. (Nasdaq:TARO) today announced the completion of a $50 million offering of long-term, non-convertible debt to...
Taro Announces Filing of ANDA for Gabapentin Capsules, 100 mg, 300 mg, 400 mg
November 17, 2003 13:26 ET
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., Nov. 17, 2003 (PRIMEZONE) -- Taro Pharmaceutical Industries Ltd. (Nasdaq:TARO) reported today that its U.S. affiliate has filed an Abbreviated New Drug Application ("ANDA") with the...
Taro Added to Nasdaq Biotechnology Index
November 14, 2003 07:00 ET
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., Nov. 14, 2003 (PRIMEZONE)-- Taro Pharmaceutical Industries Ltd. (Nasdaq:TARO) today announced that it has been selected for inclusion in the Nasdaq Biotechnology Index (NBI). The...